Search International and National Patent Collections

1. (WO2017198114) PHARMACEUTICAL FORMULATION FOR DELAYING INCIDENCE AND/OR TREATMENT OF PULMONARY FIBROSIS

Pub. No.:    WO/2017/198114    International Application No.:    PCT/CN2017/084114
Publication Date: Fri Nov 24 00:59:59 CET 2017 International Filing Date: Sat May 13 01:59:59 CEST 2017
IPC: A61K 31/192
A61K 31/343
A61K 31/365
A61K 31/366
A61P 11/00
Applicants: EVERFRONT BIOTECH INC.
长弘生物科技股份有限公司
Inventors: SU, Hong-Lin
苏鸿麟
LIN, Shinn-Zong
林欣荣
HARN, Horng-Jyh
韩鸿志
CHIOU, Tzyy-Wen
邱紫文
CHUANG, Hong-Meng
庄弘盟
Title: PHARMACEUTICAL FORMULATION FOR DELAYING INCIDENCE AND/OR TREATMENT OF PULMONARY FIBROSIS
Abstract:
An application using an active ingredient for preparing a pharmaceutical formulation. The pharmaceutical formulation is used for delaying the incidence and/or treatment of a pulmonary fibrosis. The active ingredient is selected from the following groups: a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a combination of the compound and the salt, wherein A is a five-carbon alkyl or alkenyl group comprising substituents listed in the following as required: -OH and =O; X is H or OH; Y is O; and if R1 is H or does not exist, then Y and A can form a bond to form a five-membered ring.